» Articles » PMID: 21970955

Pax5: a Master Regulator of B Cell Development and Leukemogenesis

Overview
Journal Adv Immunol
Date 2011 Oct 6
PMID 21970955
Citations 128
Authors
Affiliations
Soon will be listed here.
Abstract

The B cell lineage of the hematopoietic system is responsible for the generation of high-affinity antibodies, which provide humoral immunity for protection against foreign pathogens. B cell commitment and development depend on many transcription factors including Pax5. Here, we review the different functions of Pax5 in regulating various aspects of B lymphopoiesis. At B cell commitment, Pax5 restricts the developmental potential of lymphoid progenitors to the B cell pathway by repressing B-lineage-inappropriate genes, while it simultaneously promotes B cell development by activating B-lymphoid-specific genes. Pax5 thereby controls gene transcription by recruiting chromatin-remodeling, histone-modifying, and basal transcription factor complexes to its target genes. Moreover, Pax5 contributes to the diversity of the antibody repertoire by controlling V(H)-DJ(H) recombination by inducing contraction of the immunoglobulin heavy-chain locus in pro-B cells, which is likely mediated by PAIR elements in the 5' region of the V(H) gene cluster. Importantly, all mature B cell types depend on Pax5 for their differentiation and function. Pax5 thus controls the identity of B lymphocytes throughout B cell development. Consequently, conditional loss of Pax5 allows mature B cells from peripheral lymphoid organs to develop into functional T cells in the thymus via dedifferentiation to uncommitted progenitors in the bone marrow. Pax5 has also been implicated in human B cell malignancies because it can function as a haploinsufficient tumor suppressor or oncogenic translocation fusion protein in B cell precursor acute lymphoblastic leukemia.

Citing Articles

Whole transcriptome sequencing of testis and epididymis reveals genes associated with sperm development in roosters.

Guo S, Cong B, Zhu L, Zhang Y, Yang Y, Qi X BMC Genomics. 2024; 25(1):1029.

PMID: 39497056 PMC: 11533344. DOI: 10.1186/s12864-024-10836-8.


Establishment of CD1b-restricted immunity to lipid antigens in the pulmonary response to infection.

Harris M, Gary H, Cooper S, Ackart D, DiLisio J, Basaraba R Infect Immun. 2024; 92(12):e0038024.

PMID: 39494875 PMC: 11629625. DOI: 10.1128/iai.00380-24.


Post-translational control of B lineage commitment.

Nie J, Ng A, Nutt S Nat Immunol. 2024; 25(12):2173-2175.

PMID: 39487350 DOI: 10.1038/s41590-024-02019-0.


Targeting DLBCL by mutation-specific disruption of cancer-driving oncogenes.

Heshmatpour N, Kazemi S, Schmidt N, Patnaik S, Korus P, Wilkens B Front Genome Ed. 2024; 6:1427322.

PMID: 39469218 PMC: 11513324. DOI: 10.3389/fgeed.2024.1427322.


A SIRT7-dependent acetylation switch regulates early B cell differentiation and lineage commitment through Pax5.

Gamez-Garcia A, Espinosa-Alcantud M, Bueno-Costa A, Alari-Pahissa E, Marazuela-Duque A, Thackray J Nat Immunol. 2024; 25(12):2308-2319.

PMID: 39424985 PMC: 11588656. DOI: 10.1038/s41590-024-01995-7.